HELION BIOTECH ApS: Financial statements 2023
CVR: 31758106
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
HELION BIOTECH ApS (CVR 31758106) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 25,698 and a net result of DKK -48,167 compared with DKK 21,561 the year before. That is a decrease of 22.6% compared with the year before. Equity in the 2023 report amounted to DKK 193,428. The solvency ratio was 77%.
- Gross Profit
- DKK 25,698
- Profit/Loss
- DKK -48,167
- Equity
- DKK 193,428
- Total Assets
- DKK 251,046
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 26K | -48K | 193K | - |
| 2022 | - | 33K | 22K | 242K | - |
| 2021 | - | 55K | 11K | 220K | - |
| 2020 | - | 34K | 28K | 209K | - |
| 2019 | - | -18K | -23K | 181K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
HELION BIOTECH ApS has published its annual report for 2022. Gross profit came to DKK 33,212, and the net result was DKK 21,561.
About HELION BIOTECH ApS
HELION BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The board consists of Steffen Thiel (chair), Jens Christian Jensenius and Per Bo Pedersen Fischer. The company is owned by HELION HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -27,115 and a net result of DKK -32,019 compared with DKK -43,895 the year before. Equity in the 2025 report amounted to DKK 117,514.